Kepley Biosystems

Kepley Biosystems’ is pioneering sustainable approaches to harvesting horseshoe crab blood, a vital resource for the medical industry. Kepley Biosystems’ President, Anthony Dellinger, was thrilled when the company secured its first NSF SBIR award in 2015—but that excitement was tempered by the anxiety when he realized the complex accounting and compliance requirements that come with government funding. Following a recommendation from a fellow awardee, Mr. Dellinger partnered with EGC to manage the company’s financial and regulatory obligations. Based on a tip he received from a fellow awardee, Mr. Dellinger called EGC to support the firm’s accounting and compliance needs. For the past 10 years, EGC’s Accounting team has supported Kepley Biosystems as they have secured additional funding from the NSF SBIR program and other funding agencies. 

EGC’s partnership with Kepley Biosystems includes establishing a compliant financial system, navigating evolving federal requirements, and supporting the company through multiple SBIR awards and additional funding. With a strong financial foundation in place, Kepley’s leadership has been able to stay focused on advancing its core mission: developing innovative technologies that promote environmental sustainability.